Subgroup | X | SD |
---|---|---|
A1(Activa bioactive on PCL-NC-HA scaffold) | 8.15a | .24 |
A2 ( TheraCal on PCL-NC-HA scaffold) | 7.98a,b | .37 |
A3 (MTA on PCL-NC-HA scaffold) | 8.74c | .31 |
A4 (PCL-NC-HA scaffold) | 7.71b | .40 |
B1(Activa bioactive on PCL-NC-HA scaffold) | 10.08 a | .36 |
B2 ( TheraCal on PCL-NC-Mg-HA scaffold) | 10.29 a | .34 |
B3 (MTA on PCL-NC-Mg-HA scaffold) | 11.65 b | .37 |
B4 (PCL-NC-Mg-HA scaffold) | 9.59c | .34 |
One Way ANOVA ( P Value) | <.001* |